Galectin-8 elicits pro-inflammatory activities in the endothelium

Glycobiology

Volumn 24, Issue 10, 2014, Pages 966-973

  Cattaneo, Valentina ^a   Tribulatti, María Virginia ^a   Carabelli, Julieta ^a   Carestia, Agostina ^b   Schattner, Mirta ^b   Campetella, Oscar ^a  

^a INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Endothelial cell; Galectin 8; Inflammation; Platelets

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CXCL1 CHEMOKINE; CXCL3 CHEMOKINE; GALECTIN 8; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; LACTOSE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; VON WILLEBRAND FACTOR; GALECTIN; LGALS8 PROTEIN, HUMAN; LIPOPOLYSACCHARIDE;

ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL ACTIVATION; CELL FUNCTION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; THROMBOCYTE ADHESION; VASCULAR ENDOTHELIUM; CHEMISTRY; ENDOTHELIUM; GENETICS; METABOLISM; TANDEM REPEAT;

ENDOTHELIUM; GALECTINS; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; TANDEM REPEAT SEQUENCES;

EID: 84925657958     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu060     Document Type: Article

References (32)

1. Al-Ansari S, Zeebregts CJ, Slart RH, Peppelenbosch M, Tio RA. 2009. Galectins in atherosclerotic disease. Trends Cardiovasc Med. 19: 164-169.
2. Bombeli T, Schwartz BR, Harlan JM. 1999. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood. 93: 3831-3838.
3. Cattaneo V, Tribulatti MV, Campetella O. 2011. Galectin-8 tandem-repeat structure is essential for T-cell proliferation but not for co-stimulation. Biochem J. 434: 153-160.
4. Chen J, Lopez JA. 2005. Interactions of platelets with subendothelium and endothelium. Microcirculation. 12: 235-246.
5. Dabelic S, Novak R, Goreta SS, Dumic J. 2012. Galectin-3 expression in response to LPS, immunomodulatory drugs and exogenously added galectin-3 in monocyte-like THP-1 cells. In Vitro Cell Dev Bio-Animal. 48: 518-527.
6. Delgado VM, Nugnes LG, Colombo LL, Troncoso MF, Fernandez MM, Malchiodi EL, Frahm I, Croci DO, Compagno D, Rabinovich GA, et al. 2011. Modulation of endothelial cell migration and angiogenesis: A novel function for the "tandem-repeat" lectin galectin-8. FASEB J. 25: 242-254.
7. Devalaraja RM, Nanney LB, Du J, Qian Q, Yu Y, Devalaraja MN, Richmond A. 2000. Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol. 115: 234-244.
8. Di Gregoli K, Johnson JL. 2012. Role of colony-stimulating factors in atherosclerosis. Curr Opin Lipidol. 23: 412-421.
9. Elola MT, Wolfenstein-Todel C, Troncoso MF, Vasta GR, Rabinovich GA. 2007. Galectins: Matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci. 64: 1679-1700.
10. Eshkar Sebban L, Ronen D, Levartovsky D, Elkayam O, Caspi D, Aamar S, Amital H, Rubinow A, Golan I, Naor D, et al. 2007. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. J Immunol. 179: 1225-1235.
11. Ferre S, Baldoli E, Leidi M, Maier JA. 2010. Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFKB. Biochim Biophys Acta. 1802: 952-958.
12. Ferroni P, Vazzana N, Riondino S, Cuccurullo C, Guadagni F, Davi G. 2012. Platelet function in health and disease: From molecular mechanisms, redox considerations to novel therapeutic opportunities. Antiox Redox Signal. 17: 1447-1485.
13. He J, Baum LG. 2006. Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration. Lab Inv. 86: 578-590.
14. Jones CI, Barrett NE, Moraes LA, Gibbins JM, Jackson DE. 2012. Endogenous inhibitory mechanisms and the regulation of platelet function. Methods Mol Biol. 788: 341-366.
15. Liu FT, Rabinovich GA. 2010. Galectins: Regulators of acute and chronic inflammation. Ann NY Acad Sci. 1183: 158-182.
16. McPherson R, Davies RW. 2012. Inflammation and coronary artery disease: Insights from genetic studies. Can J Cardiol. 28: 662-666.
17. Nishi N, Shoji H, Seki M, Itoh A, Miyanaka H, Yuube K, Hirashima M, Nakamura T. 2003. Galectin-8 modulates neutrophil function via interaction with integrin alphaM. Glycobiology. 13: 755-763.
18. Norling LV, Perretti M, Cooper D. 2009. Endogenous galectins and the control of the host inflammatory response. J Endocrinol. 201: 169-184.
19. Padilla A, Moake JL, Bernardo A, Ball C, Wang Y, Arya M, Nolasco L, Turner N, Berndt MC, Anvari B, et al. 2004. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood. 103: 2150-2156.
20. Patnaik SK, Potvin B, Carlsson S, Sturm D, Leffler H, Stanley P. 2006. Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells. Glycobiology. 16: 305-317.
21. Romaniuk MA, Tribulatti MV, Cattaneo V, Lapponi MJ, Molinas FC, Campetella O, Schattner M. 2010. Human platelets express and are activated by galectin-8. Biochem J. 432: 535-547.
22. Saint-Lu N, Oortwijn BD, Pegon JN, Odouard S, Christophe OD, de Groot PG, Denis CV, Lenting PJ. 2012. Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factor. Arterioscler Thromb Vasc Biol. 32: 894-901.
23. Stancic M, van Horssen J, Thijssen VL, Gabius HJ, van der Valk P, Hoekstra D, Baron W. 2011. Increased expression of distinct galectins in multiple sclerosis lesions. Neuropathol Appl Neurobiol. 37: 654-671.
24. Suffee N, Richard B, Hlawaty H, Oudar O, Charnaux N, Sutton A. 2011. Angiogenic properties of the chemokine RANTES/CCL5. Biochem Soc Trans. 39: 1649-1653.
25. Thijssen VL, Hulsmans S, Griffioen AW. 2008. The galectin profile of the endothelium: Altered expression and localization in activated and tumor endothelial cells. Am J Pathol. 172: 545-553.
26. Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, et al. 2006. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA. 103: 15975-15980.
27. Tribulatti MV, Cattaneo V, Hellman U, Mucci J, Campetella O. 2009. Galectin-8 provides costimulatory and proliferative signals to T lymphocytes. J Leuk Biol. 86: 371-380.
28. Tribulatti MV, Figini MG, Carabelli J, Cattaneo V, Campetella O. 2012. Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of Tcell responses. J Immunol. 188: 2991-2999.
29. Tribulatti MV, Mucci J, Cattaneo V, Aguero F, Gilmartin T, Head SR, Campetella O. 2007. Galectin-8 induces apoptosis in the CD4(high) D8 (high) thymocyte subpopulation. Glycobiology. 17: 1404-1412.
30. Wagner DD 1993. The Weibel-Palade body: The storage granule for von Willebrand factor and P-selectin. Thromb Haemost. 70: 105-110.
31. Xia M, Sui Z. 2009. Recent developments in CCR2 antagonists. Expert Opin Ther Pat. 19: 295-303.
32. Yamamoto H, Nishi N, Shoji H, Itoh A, Lu LH, Hirashima M, Nakamura T. 2008. Induction of cell adhesion by galectin-8 and its target molecules in Jurkat T-cells. J Biochem. 143: 311-324.